A novel polyketide fermentation product produced by Streptomyces chromofuscus, originally discovered by screening for herbicidal activity. Potent and selective inhibitor of spliceosome subunit SF3b. Specifically targets SAP155, a subunit of SF3b responsible for pre-mRNA splicing. Displays anti-angiogenic activity via down-regulation of VEGFR-2 and HIF-1α. Spliceosome inhibitors have attracted enormous attention due to their potential use in cancer treatment.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Regulatory Status |
RUO – Research Use Only |
---|